5-fluorouracil encapsulated alginate beads for the treatment of breast cancer

被引:77
作者
Arica, B
Çalis, S [1 ]
Kas, HS
Sargon, MF
Hincal, AA
机构
[1] Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Anat, TR-06100 Ankara, Turkey
关键词
5-fluorouracil; alginate beads; biodegradable polymers; breast cancer;
D O I
10.1016/S0378-5173(02)00172-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alginate beads containing 5-fluorouracil (5-FU) were prepared by the gelation of alginate with calcium cations. Alginate beads loaded with 5-FU were prepared at 1.0 and 2.0% (w/v) polymers. The effect of polymer concentration and the drug loading (1.0, 5.0 and 10%) on the release profile of 5-FU was investigated. As the drug load increased, larger beads were obtained in which the resultant beads contained higher 5-FU content. The encapsulation efficiencies obtained for 5-FU loads of 1.0, 5.0 and 10% (w/v) were 3.5, 7.4 and 10%, respectively. Scanning electron microscopy (SEM) and particle size analysis revealed differences between the formulations as to their appearance and size distribution. The amount of 5-FU released from the alginate beads increased with decreasing alginate concentrations. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:267 / 269
页数:3
相关论文
共 6 条
[1]   Effect of gelation conditions and dissolution media on the release of paracetamol from alginate gel beads [J].
Aslani, P ;
Kennedy, RA .
JOURNAL OF MICROENCAPSULATION, 1996, 13 (05) :601-614
[2]  
CALIS S, 2002, CHITOSAN PHARM CHEM, P65
[3]   ALGINATE CONTROLLED RELEASE FORMULATIONS OF METRIBUZIN [J].
PEPPERMAN, AB ;
KUAN, JCW ;
MCCOMBS, C .
JOURNAL OF CONTROLLED RELEASE, 1991, 17 (01) :105-111
[4]   THE CONTROLLED-RELEASE OF PREDNISOLONE USING ALGINATE GEL [J].
SUGAWARA, S ;
IMAI, T ;
OTAGIRI, M .
PHARMACEUTICAL RESEARCH, 1994, 11 (02) :272-277
[5]   Formulation and investigation of nicardipine HCl-alginate gel beads with factorial design-based studies [J].
Takka, S ;
Ocak, OH ;
Acarturk, F .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 6 (03) :241-246
[6]  
Torre M L, 1998, Pharm Dev Technol, V3, P193, DOI 10.3109/10837459809028495